At present, RBM15 has been studied widely in various blood diseases, such as chronic myelogenous leukemia (CML), acute megakaryocytic leukemia, and T−cell acute lymphoblastic leukemia. Here, RBM15 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.